zuSyn is a new Kalamazoo-based company focused on the
development of new anticancer drugs using proprietary glycochemistry in
order to modify
known natural product scaffolds. The result will be new drug candidates
with enhanced solubility, bioavailability and broader indications.
Latest News
New Life Science Start-Up Receives Funding and
Opens Lab 
